0 likes | 14 Views
What sets Letermovir apart is not only its efficacy but also its favorable safety profile. Letermovir 240 mg in India offers a compelling solution for the prevention and treatment of CMV infection, addressing an unmet medical need and improving the standard of care for HSCT recipients. It is also approved for the treatment of CMV infection and disease in adult HSCT recipients who have demonstrated evidence of CMV replication post-transplantation. By staying abreast of emerging evidence and guidelines, Impomed Healthcare harnesses the full potential of this drug for its patients.
E N D